Delivery Order SPE2DB22D3010-SPE2DB25FP3BC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This firm fixed-price delivery order, issued on July 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Norditropin Flexpro 10 mg/1.5 1.5 mL pharmaceutical products. The $6,208.52 order has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,499.03 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication. The contract, issued on July 21, 2025, with completion targeted for July 22, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,012.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $146,358.90, is for the delivery of Norditropin FlexPro 15 mg/1.5 ml, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a period of performance ending on June 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 15 mg/1.5 ml medication. The $1,047.69 firm fixed-price contract has a performance period extending to May 15, 2025. AmerisourceBergen Drug Corp is the prime contractor and this award is not associated with a set-aside designation, indicating open competition. The contract is part of the company's broader Indefinite...
- The Defense Logistics Agency awarded a $21,466.53 delivery order to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,451.37 firm fixed price delivery order is for the supply of Norditropin FlexPro 10 mg/1.5 1.5 ml, a medication used to treat certain medical conditions. The contract has an ultimate completion date of July 16, 2025 and was awarded on July 15, 2025. It is not designated as a set-aside contract, indicating open...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a pharmaceutical product. The award has a potential value of $3,507.24 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This delivery order is issued under a larger indefinite delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,793.84, is for the delivery of Norditropin Flexpro 15 mg/1.5 1.5 ml, a medication used for the treatment of various medical conditions. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3BCDelivery Order
The Defense Logistics Agency awarded a $5,640.36 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor through its prime vendor agreement with the Defense Logistics Agency. The SPE2DX contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including products for specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine fulfillment under that overarching prime vendor arrangement, supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/25/25 |